Welcome to our dedicated page for Inogen news (Ticker: INGN), a resource for investors and traders seeking the latest updates and insights on Inogen stock.
Inogen Inc (INGN) is a pioneering medical technology company specializing in portable oxygen concentrators for respiratory care. This dedicated news hub provides investors and healthcare professionals with essential updates on product developments, regulatory milestones, and strategic initiatives.
Access timely announcements including quarterly earnings reports, FDA clearances for new devices, partnership agreements with healthcare providers, and clinical study results. Our curated collection ensures you stay informed about innovations in oxygen therapy technology and market expansion efforts.
Key focus areas include advancements in lightweight oxygen systems, international distribution updates, and operational developments impacting respiratory patient care. Bookmark this page for direct access to primary source materials and analyzed updates from INGN's corporate communications.
Inogen, Inc. (Nasdaq: INGN) is set to announce its first quarter 2023 financial results after market close on May 4, 2023. The company will host a conference call on the same day at 2:00 p.m. PT / 5:00 p.m. ET. Investors can access the call by dialing (888) 645-4404 for US callers and (862) 298-0702 for international callers. A live webcast will also be available on Inogen’s Investor Relations website at http://investor.inogen.com/, which will be archived for six months. A replay of the call will be accessible starting three hours post-call until May 11, 2023.
Inogen, Inc. (Nasdaq: INGN) announced its participation in the 22nd Annual Needham Virtual Healthcare Conference on April 19, 2023, at 12:45 p.m. ET. The event will include a live audio webcast and an archived recording accessible via the News / Events section of Inogen's Investor Relations website. As a leader in the medical technology sector, Inogen specializes in innovative respiratory products for homecare settings, focusing on portable oxygen concentrators for chronic respiratory conditions. For more details, visit www.inogen.com.
Inogen, Inc. has appointed Tom West to its Board of Directors, effective April 1, 2023, while Kristen Miranda will retire on March 31, 2023. Tom West brings extensive experience from various leadership roles in the medical technology sector, including his recent position as CEO of Intersect ENT, Inc.. The Board's chair, Elizabeth Mora, emphasizes West's potential to enhance Inogen's strategic initiatives and operational efficiency. West expressed enthusiasm for driving growth at Inogen, which specializes in respiratory care products. This change is part of the company's efforts to strengthen its leadership amidst ongoing transformation.
Inogen, a medical technology company focused on innovative respiratory products, will participate in a virtual fireside chat at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on March 21, 2023, at 2:15 p.m. Eastern Time. The chat aims to enhance engagement with investors and provide insights into Inogen's operations. A live audio webcast and an archived recording will be accessible through the company's Investor Relations website. Inogen specializes in portable oxygen concentrators, supporting patients with chronic respiratory conditions.
FAQ
What is the current stock price of Inogen (INGN)?
What is the market cap of Inogen (INGN)?
